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Interleukin-1 receptor antagonist attenuates the
severity of spinal cord ischemic injury in rabbits
Satoshi Akuzawa, MD, Teruhisa Kazui, MD, PhD, Enyi Shi, MD, PhD, Katsushi Yamashita, MD, PhD,
Abul Hasan Muhammad Bashar, MBBS, PhD, and Hitoshi Terada, MD, PhD, Hamamatsu, Japan
Objective: Thoracic and thoracoabdominal aortic surgery is sometimes complicated by subacute or delayed paraplegia.
Pro-inflammatory cytokine interleukin-1 (IL-1)  has been implicated in extensive inflammation and progressive
neurodegeneration after ischemia. Using a rabbit model, we investigated the neuroprotective effects of IL-1 receptor
antagonist (IL-1ra) in a temporal fashion.
Methods: Spinal cord ischemia was induced by aortic cross-clamping in New Zealand White rabbits. The animals were
assigned to three groups. Group C (n  20) received saline (0.2-mL) and Group I (n  20) received IL-1ra
(200-g/0.2-mL) intrathecally just after reperfusion. Group S (n  3) underwent sham operation without aortic
occlusion. We assessed the neuroprotective effects of IL-1ra by evaluating neurological function, histopathological
changes, and in-situ terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling (TUNEL staining).
We alsomeasured the levels of Nitric Oxide (NO) and S100 in cerebrospinal fluid (CSF). Each evaluation was performed
sequentially within 120 hours after reperfusion.
Results:GroupC showed progressive deterioration of motor function which became statistically significant from 48 hours
after the onset of reperfusion (P< .05, P< .01, P< .001, P< .001 at 48, 72, 96, and 120 hours, respectively). Compared
to Group C, a higher number of viable neurons was observed with less severe spinal cord injury in Group I (P < .01, .05
and .05 at 24, 72, and 120 hours, respectively). TUNEL-positive neurons were also significantly reduced by the
administration of IL-1ra (P <.01 and .05 at 24, and 120 hours, respectively). The difference between Group C and
Group I with regard to NO was significant at 72 and 120 hours (P < .05), while that in terms of S100 was significant
only at 24 hours (P < .05).
Conclusions: Administration of IL-1ra attenuates spinal cord ischemic-reperfusion injury as evidenced by reducing both
neuronal necrosis and apoptosis. ( J Vasc Surg 2008;48:694-700.)
Clinical Relevance: The present study explores the possibility of reducing subacute or delayed paraplegia after thoraco-
abdominal aortic surgery using a pharmacological agent that is already available for clinical use. IL-1 mediated
inflammatory reaction after ischemic insult can be thought as one of the mechanisms responsible for delayed infarct
expansion leading to subacute or delayed paraplegia. IL-1ra has known anti-inflammatory properties and was therefore
expected to suppress such post-ischemic inflammatory reaction, if given at an appropriate time. The results of the present
study indicate that IL-1-targetted anti-cytokine therapy can be a potentially useful strategy for the attenuation of
neurological injury after spinal cord ischemia.Paraplegia or paraparesis is a serious complication re-
sulting from spinal cord ischemia during descending or
thoracoabdominal aortic surgery. Various methods have
been suggested for the prevention of this complication such
as topical cooling, partial bypass, distal aortic perfusion,
intercostal artery reimplantation, and cerebrospinal fluid
drainage.1-3 However, despite the use of these adjuncts,
paraplegia still remains a disastrous and unpredictable com-
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694plication. With a view to further reducing the incidence of
paraplegia, we undertook a number of experimental studies
in the previous years and evaluated the potential merit of
various pharmacologic agents for spinal cord ischemia.4-6
These studies revealed the promises of novel therapeutics in
the prevention of spinal cord ischemic injuries.
Pro-inflammatory cytokine interleukin-1 (IL-1)  has
been implicated in extensive inflammation and progressive
neurodegeneration after ischemia.7,8 It is also reported that
administration of recombinant human IL-1 receptor antag-
onist (IL-1ra) helps in the attenuation of neural damage in
cerebral ischemia.9 IL-1ra is already in clinical use indicated
for severe rheumatoid arthritis. However, the possible ef-
fect of this agent on spinal cord ischemia has not yet been
investigated. In the clinical setting, paraplegia sometimes
occurs in sub-acute or delayed phase after thoracic or
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suppression of inflammatory reaction after ischemia with
IL-1ra has the potential of attenuating the severity of the
spinal cord injury. We undertook this animal study to
demonstrate the neuroprotective effects of IL-1ra after
spinal cord ischemia in a temporal fashion.
METHODS
Experimental animals and materials. We used male
New Zealand White rabbits weighing between 2.5 and
3.0-kg in this study (Japan SLC, Inc. Hamamatsu, Japan).
Recombinant human IL-1ra, Anakinra was supplied by
Amgen Inc (Thousand Oaks, Calif), at a concentration of
100mg/mL (in: 10-mM citrate, 140-mM NaCl, 0.5-mM
EDTA, pH 6.5), which we diluted with sterile 0.9% NaCl
prior to injection.
Animal care and surgical procedure. The animal
protocol was approved by the Ethics ReviewCommittee for
Animal Experimentation of Hamamatsu University School
of Medicine and all animals received humane care in com-
pliance with the “Guide for the Care andUse of Laboratory
Animals” prepared by the Institute of Laboratory Animal
Resources, National Research Council, and published by
the National Academy Press (revised 1996).
The rabbits were anesthetized with intravenous sodium
pentobarbital (25-mg/kg) and allowed to breathe sponta-
neously. First, the catheter was inserted intrathecally for
drug delivery (described below). The animal was then
placed in the supine position and the infrarenal abdominal
aorta was exposed through a transperitoneal approach.
After intravenous administration of heparin (100-U/kg),
spinal cord ischemia was induced by cross-clamping the
aorta just below the renal arteries and just above the aortic
bifurcation for 21 minutes. The clamps were then released
and the flank was closed in two layers. At the end of the
protocol, the animal was euthanized with a lethal dose of
pentobarbital (200-mg/kg) and the spinal cord (L4 to L6)
was quickly harvested. Rectal temperature was continu-
ously monitored throughout the procedure with a flexible
probe (TerumoMedical Co, Tokyo, Japan) andmaintained
at about 38.5°C with heating lamp and electric blanket
(Sharp Co, Osaka, Japan).
Intrathecal injection. Intrathecal injection technique
was conducted according to the method described by our
department previously.11 After inducing the general anes-
thesia, the intervertebral space between L6 and L7 was
punctured with a 16-gauge needle and a polyethylene tube
was inserted through it into the subarachnoid space. The
desired position of the catheter was confirmed by cautious
aspiration of cerebrospinal fluid. The catheter was removed
after intrathecal injection of either IL-1ra or vehicle alone.
Experimental protocol and drug delivery. A total of
43 animals were assigned to three groups in a random
fashion. Group S (n 3) underwent sham operation with-
out aortic occlusion. Intervertebral puncture with catheter
insertion was done in this group without drug or saline
injection. Group C (n  20) received saline (0.2-mL) and
Group I (n 20) received IL-1ra (200-g/0.2-mL) intra-thecally after an equal volume of CSF (0.2-mL) was with-
drawn. All intrathecal injection was performed at the onset
of reperfusion. In this study, we applied a 21-minute ob-
struction of the abdominal aorta. Three rabbits fromGroup
S and eight each from Group C and Group I were eutha-
nized at 120 hours after the beginning of reperfusion. Six
rabbits each fromGroup C and Group I were euthanized at
24 and 72 hours respectively for histopathological and
biochemical examinations. CSF was withdrawn for bio-
chemical assessment after the final evaluation of motor
function.
Neurological evaluation. Hind-limb motor function
was scored at every 24 hours after reperfusion using the
modified Tarlov scale as follows; 0  no movement; 1 
slight movement; 2 sit with assistance; 3 sit alone; 4
weak hop; 5 normal hop.12 The neurological assessment
was performed by an observer without knowledge of the
protocol.
Histopathological examination. The harvested lum-
bar spinal cord was fixed overnight in 10% buffered forma-
lin. Paraffin-embedded spinal cord sections were processed
for hematoxylin and eosin staining, and histopathological
evaluation was performed under a light microscope. The
examination included a count of the viable neurons per
section in the ventral gray matter and a graded histological
damage scoring (Table I).13 Slides were examined by a
pathologist blinded to the experimental protocol. Readings
from 3 sections were taken and values were averaged at 24,
72, and 120 hours after reperfusion.
TUNEL staining. Paraffin-embedded sections were
used for in situ terminal deoxynucleotidyl transferase-
mediated dUTP-biotin nick end labeling (TUNEL) with
Apoptosis in situ Detection Kit Wako (Wako Co, Osaka,
Japan). The sections were counterstained with hematoxy-
lin. Slides were examined by a blinded observer. The ratio
of TUNEL–positive neurons relative to the total neural
cells in the gray matter was calculated in 3 sections, and the
values were averaged at 24, 72, and 120 hours after reper-
fusion.
Biochemical examination of CSF. CSF was stored at
-80°C and thawed at room temperature just before exam-
inations. The levels of Nitric Oxide (NO) and S100
protein were measured with NO (NO2
/NO3
) Assay Kit
Table 1. Semiquantitative score for histopathologic
assessment of ischemic spinal cord injury
Histopathologic assessment Score
Healthy 0
Perineural edema or scattered single-cell necrosis 1
Unilateral necrosis of the central medial portion of
anterior horn 2
Bilateral necrosis of the central medial portion of
anterior horn 3
Unilateral necrosis of the entire anterior horn 4
Bilateral necrosis of the entire anterior horn 5(Assay Designs Inc, Ann Arbor, Mich) and Sangtec 100
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NO was measured from the values of total Nitrite (NO2
)
and Nitrate (NO3
) detected by the colorimetric Griess
reaction that absorbs visible light at 540nm after the enzy-
matic conversion. S100 protein level was measured by a
two-site, one-step, enzyme linked immunosorbent assay
with capture antibodies, a detector antibody with horserad-
ish peroxidase and tetramethylbemzidine chromogen.
Samples were diluted 50 times with diluting solution. The
absorbance was measured at 450-nm.
Statistical analysis. The data are presented as mean
standard deviation (SD). Statistical analysis of physiologic
parameters was performed with one-way analysis of vari-
ance (ANOVA). Comparative analysis of neurological re-
covery score between Group C and Group I was performed
by two-way repeated measure ANOVA with Bonferonni’s
post-hoc test. The non-parametric Mann-Whitney U test
was used for comparison between Group C and Group I,
with respect to histologic score, the number of the viable
neurons, the ratio of TUNEL-positive neurons and the
levels of NO and S100 in CSF. Statistical significance was
defined as a P-value of less than .05.
RESULTS
Physiologic parameters. Mean body weight along
with the baseline rectal temperature of each animal was
measured before the induction of anesthesia, while the
lowest rectal temperature was recorded during the experi-
ment. There were no significant differences in these param-
eters among the sham, control, and IL-1ra treated groups.
Neurological assessment. Eight animals each from
Group C and Group I were observed until 120 hours after
reperfusion and were subjected to comparative analysis of
Fig 1. Neurological function scaled by modified Tarlov score at
24, 48, 72, 96, 120 hours after the beginning of reperfusion.
Triangles, squares, and circles represent average score of each
group while bars show standard deviation (SD). Group I had
significantly higher scores in comparison with Group C after 48
hours from the beginning of reperfusion (*P  .05, **P  .01,
#P  .001).motor function (Fig 1). The rabbits euthanized earlier (at24 [n  6] and 72 [n  6] hours) for histopathologic and
biochemical examinations had no significant differences at
similar time points compared with the remaining animals of
the same group in terms of neurological outcome. All
rabbits in Group S were normal throughout the observa-
tion period. Twenty one minutes of aortic occlusion resulted
in severe progressive deterioration of hind-limb motor func-
tion inGroupC.Treatmentwith IL-1ra remarkably enhanced
the preservation of motor function starting from 48 hours
after the beginning of reperfusion (Fig 1; Group C vs Group
I; P .05, P .01, P .001, P .001 at 48, 72, 96, and
120 hours, respectively).
Histopathological assessment. Representative pho-
tographs of the tissue sections stained with hematoxylin
and eosin are shown in Fig 2. The count of viable neurons
as evidenced by clear nucleoli and Nissl substance in the
ventral gray matter and histological injury score are sum-
marized in Fig 3. In the sham operated animals, the spinal
cord was intact and many large neurons were present in the
anterior horn. Severe neuronal damage was induced in
Group C, as evidenced by a reduced number of viable
neurons with higher histological injury score. In contrast,
there were fewer evidences of neuronal damage in Group I
(Fig 2, 3). Significant differences were found between Group
C andGroup I in terms of the number of viable neurons at 24,
72, and 120 hours (Fig 3, A; Group C vs Group I; P  .01,
.05 and .05 at 24, 72, and 120 hours, respectively). The
differences in histological score reached statistical significance
at 24 and 120 hours (Fig 3, B; Group C vs Group I; P .01
and .05 at 24 and 120 hours, respectively). There was no
evidence of significant macro or microscopic injury caused by
intervertebral puncture in any of the animals.
TUNEL staining. Neurons with double-strand breaks
in DNA— a feature suggestive of apoptosis — were detected
in TUNEL staining by their brown and granular nuclei.
Representative photographs of the TUNEL-stained tissue
sections along with the ratio between TUNEL-positive and
total neurons are shown in Fig 4. Group S had very few cells
with evidence of TUNEL-positivity, while numerous scat-
tering TUNEL-positive neurons were detected in Group C
(Fig 4, A). Administration of IL-1ra remarkably reduced
the ratio between TUNEL-positive and total neurons com-
pared with that in Group C (Fig 4, B; Group C vs Group I;
P  .05 at 24 and 72 hours and P  .01 at 120 hours,
respectively).
Biochemical examination of CSF. The levels of NO
and S100 in CSF are shown in Fig 5. Higher concentra-
tions of these parameters were seen until 120 hours after
reperfusion in Group C. The difference between Group C
and Group I with regard to S100 was significant at 24
hours (Fig 5, A; P  .05), while that in terms of NO was
significant at 72 and 120 hours (Fig 5, B; P  .05 at both
72 and 120 hours).
DISCUSSION
Cerebral infarct expansion is thought to continue for
several days subsequent to the initial infarct expansion that
occurs within the first 24 hours.14,15 The expression of
I (*P
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reperfusion and continues for several days in the brain and
can be detected on microglia, perivascular macrophage,
Fig 2. Representative sections of the spinal cord stained
examined with two different magnifications (left panel:
spinal cord of the Group S animals was largely intact (A)
with vacuolization and gliosis of the gray matter (B). In G
with only slight vacuolization (C).
Fig 3. Bar graph showing the number of remaining viab
injury score at 24, 72, and 120 hours after the beginnin
progressive neurodegeneration, whereas there were few
viable neurons and low histological injury score in Groupand astrocyte.16,17 Previous studies have shown that neuralinflammation which induces pro-cytokine IL-1 plays a key
role in this process involving the glial cells as well as the
invading immune cells and has detrimental effect on central
hematoxylin and eosin. Sections from each group were
bar  1-mm, right panel: 200, bar  100-m). The
roup C, spinal cords showed spread of necrotic changes
I, normal-lookingmotor neurons were largely preserved
urons in the ventral gray matter (A) and the histological
eperfusion (B) in the spinal cord sections. Group C had
idences of neuronal damages with a higher number of
 .01, **P .05, ***P .05, #P .01, ##P .05).with
40,
. In G
rouple ne
g of r
er evnervous system (CNS) injury.9,17 Lu et al18 have recently
.05,
ebros
ted in
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ischemia and high concentration was maintained up to 3
days after reperfusion. They have also shown that reduction
Fig 5. Concentrations of NO (NO2/NO3) and S1
parameters were seen until 120 hours after reperfusion
regard to NO was significant at 72 and 120 hours (*P
only at 24 hours (#P  .05). NO, nitric oxide; CSF, cer
Fig 4. Representative sections of TUNEL staining (A:
TUNEL-positive neurons relative to the total neurons in th
Numerous scattering TUNEL-positive neurons were detecof IL-1 expression could lead to the attenuation of reper-fusion injury. In the present study we noted significant
progressive deterioration of motor function with histolog-
ically demonstrable neuronal injury in the control rabbits.
protein in CSF (A, B). Higher concentrations of these
oup C. Difference between Group C and Group I with
**P .05), while that in terms of S100 was significant
pinal fluid.
inal magnifications; 200, bar  20-m) with ratio of
y matter (B). Arrows show the TUNEL-positive neurons.
Group C compared with Group I (*P .05, **P .05).00
in Grorig
e graIn contrast, administration of IL-1ra led to a remarkable
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motor functions. Thus, the results of our study suggest
that IL-1 contributes to the severity of ischemia-reper-
fusion injury which can be attenuated by blocking its
signal pathways. Despite the difference in the levels of
intervention in the cytokine chain, the findings of these
two studies are basically similar in the sense that both
achieved attenuation of neuronal injury by minimizing
the effect of IL-1.
A key aspect of our study is the route of drug adminis-
tration. We preferred the intrathecal route for drug delivery
as the elimination half-life of IL-1ra is very short when
given intravenously.19 On the other hand, the drug persists
in the CNS for a significantly longer duration when given
intraventricularly. Konsman et al20 have shown that IL-1ra
injected into the lateral ventricle rapidly diffuses from the
CSF into brain parenchyma. Loddick et al21 have reported
that the effects of IL-1ra were still evident in both cortex
and striatum over 48-hour after cerebral ischemia using
intracerebroventoricular administration of this agent. The
intrathecal route also facilitated cerebrospinal fluid (CSF)
sampling for biochemical evaluations. The dosage of the
drug in the present study was decided on the basis of
previous studies in rat cerebral ischemia models.21,22 Our
decision to use a 21-minute aortic occlusion was also based
on previous studies from our laboratory with similar spinal
cord ischemic time.4,11 All experimental animals were al-
lowed to breathe spontaneously in this study like most
other studies of similar nature using rabbit spinal ischemia
model. Although spontaneous breathing may alter the level
of pCO2 after the induction of anesthesia which may
influence neuroprotection under ischemic condition, we
did not anticipate any significant differences with regard to
this parameter among the study groups as we employed the
same anesthetic protocol for all the animals in this study.
The timing of drug delivery constitutes another diffi-
cult issue. In the present study, we administered IL-1ra at
the beginning of reperfusion. We think that the initial
deterioration of neurologic status in Group I was due to the
effect of spinal ischemia itself and its resultant excitotoxic-
ity. That the histological injury scores between the two
groups did not reveal significant difference at 72 hours
could be considered a limitation of the scoring system.
In our study, the ratio between TUNEL-positive and
total countable neurons was significantly lower in the IL-
1ra treated group as compared with that in the control
group suggesting fewer apoptosis in the former group.
Apoptosis has been shown to be an important mode of
neuronal death in the ischemic spinal cord which is thought
to be occurring towards the earlier part of the ischemic
stress.23 However, in the present study, we could detect
TUNEL-positive neurons over 72 hours. This indicates
that, in addition to the initial ischemic stress, secondary
inflammatory stimuli associated with IL-1 signals cause a
more severe neurological injury, and that IL-1ra attenuates
such injury by reducing apoptotic and necrotic neuronal
death. We think that the very small number of TUNEL-positive neurons detected in Group S resulted from spinal
cord harvesting procedure.
IL-1ra acts by blocking the IL-1 receptor and its signal
pathways and does not directly inhibit its production. To
clarify the possible mechanism of ischemic neurological
injury caused by IL-1, we aimed at demonstrating the
cytotoxic mediators associated with IL-1 signals rather than
the production of IL-1 itself. Previous studies on cerebral
ischemia have demonstrated that cytotoxic factors are asso-
ciated with IL-1 signals and that the neurotoxic effect of
IL-1 could be mediated by such factors as NO and S100.
NO produced by IL-1 signal-mediated immunostimula-
tion of glial cells exacerbates ischemic neural damage in the
CNS through an oxidative process.24 Combined with su-
peroxide, NO is transformed into reactive nitrogen oxide
radical (ONOO), which is a free radical having strong
tissue toxicity.25,26 S100 is an astrocytic protein generally
known as a biomarker of neural cell damage. However, it
has recently been suggested that inhibiting the products of
S100 can be a potential therapeutic target in acute stroke
patients.27 This indicates that S100 itself might exacerbate
ischemic neuronal damage, a possible mechanism of which
might be propagation of neuroinflammation through astro-
cytic gap junction and also enhancement of NO production
in the ischemic brain.15,28 In the present study, signifi-
cantly lower levels of NO and S100 were detected in CSF
in IL-1ra-treated animals in the subacute phase after reper-
fusion. Although the production of NO and S100 is not
regulated by IL-1 signals alone, we think that it is affected
by IL-1 signals in a direct fashion and also by an unknown
secondary mechanism under the complex cytokine net-
work. We think that the reduction of these parameters
resulted in the suppression of the cytokine cycles and
attenuation of the continuous oxidative stress.
While the results of the present study are highly encour-
aging, they should be interpreted bearing in mind its limi-
tations. We performed only a two-dimensional assessment
of the histopathological severity of ischemia-induced spinal
cord injury that actually occurred in a three-dimensional
manner. Moreover, we were able to demonstrate only a few
of the possible mechanisms by which IL-1ra attenuates
neurological injury. However, to our knowledge, this is the
first report to describe the effect of this agent on spinal cord
ischemic injury. Further studies using more refined tech-
niques are warranted to elucidate the correlation between
neurological function and the extent of IL-1 mediated
ischemia-reperfusion injury of the spinal cord.
In conclusion, the administration of IL-1ra resulted in
a significant preservation of the motor function after tran-
sient spinal cord ischemia and protected spinal cord against
ischemia-reperfusion injury by reducing necrosis and apopto-
sis. This study suggests that IL-1-targetted anti-cytokine
therapy possesses therapeutic potential with regard to neu-
rological injury after spinal cord ischemia.
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